Chart (IMAGE)

CureLab Oncology Inc.

Chart

Caption

Longer exposure to Elenagen strongly correlated with longer survival following treatment discontinuation, particularly within the first 12 months

Credit

CureLab Oncology

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.